Dialysis patients undergoing percutaneous coronary interventions are at increased risk for vascular complications.

被引：0
|
作者：
Hajj-Ali, R [1 ]
Salem, M [1 ]
Park, C [1 ]
Ezzeddine, R [1 ]
Marchant, D [1 ]
Kaplan, B [1 ]
Green, S [1 ]
Katz, S [1 ]
Ong, L [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 90卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT435
引用
收藏
页码：168H / 168H
页数：1
相关论文
共 50 条
  • [21] Nephropathy requiring dialysis after percutaneous coronary interventions: Increased risk in the subset of patients exceeding a "maximum allowed contrast dose".
    Freeman, RV
    Share, D
    Maxwell-Eward, A
    O'Donnell, MJ
    Greenbaum, AB
    Meengs, WL
    Defranco, A
    Bruckman, D
    Kline-Rogers, E
    Eagle, KA
    Moscucci, M
    CIRCULATION, 2000, 102 (18) : 642 - 642
  • [22] Management of patients undergoing percutaneous vascular interventions: balancing ischaemic benefit and bleeding risk
    Luscher, Thomas F.
    EUROPEAN HEART JOURNAL, 2017, 38 (14) : 1003 - 1007
  • [23] VASCULAR ACCESS SITE COMPLICATIONS IN THE ERA OF COMPLEX PERCUTANEOUS CORONARY INTERVENTIONS
    MULLER, DWM
    PODD, J
    SHAMIR, KJ
    CIRCULATION, 1990, 82 (04) : 510 - 510
  • [24] PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN PATIENTS UNDERGOING CHRONIC DIALYSIS
    VAITKUS, PT
    GUIDERA, SA
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1993, 6 (04) : 293 - 296
  • [25] ACEF score in the risk stratification of patients undergoing percutaneous coronary interventions of chronic coronary total occlusion
    Di Serafino, L.
    Pyxaras, S. A.
    Toth, G.
    De Vroey, F.
    Bartunek, J.
    De Bruyne, B.
    Wijns, W.
    Barbato, E.
    EUROPEAN HEART JOURNAL, 2013, 34 : 876 - 876
  • [26] Validation of a risk prediction rule for vascular complications of percutaneous coronary interventions on a large independent dataset.
    Moscucci, M
    Piper, WD
    O'Connor, GT
    O'Donnell, M
    Share, D
    Malenka, DJ
    CIRCULATION, 2001, 104 (17) : 819 - 820
  • [27] Vascular complications of coronary interventions
    Davis, C
    VanRiper, S
    Longstreet, J
    Moscucci, M
    HEART & LUNG, 1997, 26 (02): : 118 - 127
  • [28] The association between activated clotting time and hemorrhagic complications in patients undergoing percutaneous coronary interventions with bivalirudin
    Martinez, JM
    Trimino, EM
    Berg, JM
    Anton, MP
    CHEST, 2003, 124 (04) : 150S - 151S
  • [29] Abciximab as an adjunctive therapy for patients undergoing percutaneous coronary interventions
    Parikh, Devang
    Juergens, Craig P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) : 235 - 246
  • [30] Optimal timing for percutaneous coronary interventions in patients undergoing TAVI
    Venturi, Gabriele
    Lunardi, Mattia
    Del Sole, Paolo Alberto
    Pighi, Michele
    Scarsini, Roberto
    Ribichini, Flavio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
12345